RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Equity Story

Home  >  Investor Relations  >  At a Glance  >  Equity Story

Global leader in Sample to Insight solutions

QIAGEN serves more than 500,000 customers with differentiated molecular solutions to enable research and the growing applications of clinical testing. Our instruments, consumables and software technologies span seamless workflows to take customers from start to finish – preparing samples, analyzing and interpreting variations, and reporting actionable findings. We are leveraging state-of-the-art technologies in our 5 Pillars of Growth (see our Strategy page for more details) to capture mid-term growth in dynamic markets.

Qiagen at a glance

Leading positions in attractive markets

Deep relationships in two major customer classes which are experiencing robust market growth:

  • Molecular Diagnostics
    • Healthcare providers transforming medicine with molecular insights for prevention, diagnosis and monitoring of diseases
  • Life Sciences
    • Scientists in academia unlocking the mysteries of life such as mechanisms, pathways and potential treatments of diseases, as well as environmental and biological questions
    • Pharmaceutical and biotechnology companies using genomic insights to guide the discovery and development of innovative new treatments
    • Government or industry laboratories meeting needs in forensics, veterinary diagnostics and food safety

    See Our customers page for more details.

Strong balance sheet, healthy cash flow, disciplined capital allocation

  • Investing in organic growth and targeted M&A to optimize profitability and shareholder value
  • Managing business growth to deliver operating leverage Strong financial position and cash flow generation

Wide global sales reach

  • Robust product portfolios and sales teams in >85 countries including North America, Europe and Asia-Pacific
  • Distribution partners in over 60 countries with further expansion in emerging markets

Committed to responsible business practices

  • Dedicated to sustainability in our operations
  • Committed to hiring and advancing a diverse global workforce
  • Strong governance at the executive and board level